News
Total Revenue, Land Agreement Proceeds and Interest was $3.6M, equating to 1,249 gold equivalent ounces. Royalty, stream, pre-production, and ...
Hosted on MSN2mon
Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue EstimatesIs now the time to buy Royalty Pharma? Find out by accessing our full research report, it’s free. ・Revenue: $594 million vs analyst estimates of $605.4 million (flat year on year, 1.9% miss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results